Borrower record · Q2 2026
Axsome Therapeutics
As filed by 3 BDCs · period end 30 June 2026NAICS 31-33 · Manufacturing
Three lenders report $116.7m of Axsome Therapeutics at Q2 2026, marked at 102.7 cents. The filed maturities run to May 2030.
- Filed fair value
- $116.7m
- 5 funded positions
- Reporting lenders
- 3
- across 5 filed positions
- Aggregate mark
- 102.7c
- cost filed on all 5 positions
- Median spread
- 438bp
- over SOFR, 4 tranches
- Maturities to
- 2030
- one date, 8 May 2030
- Periods on record
- 5
- first filed Q2 2025
How this total is counted
- Every figure above is the sum of 5 funded positions filed by 3 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
Pricing as filed
4 floating tranches · SOFRBar length is the number of tranches filed at that spread. The accented rows hold the middle tranches.
447bp weighted by fair value, across the same 4 tranches.
Capital structure
Bars show position counts. 2 of 5 funded positions carry no filed seniority.
Rate structure
Floating, on all 4 positions whose interest type a filer disclosed.
1 of 5 funded positions carries no filed interest type.
Maturity profile
4 of 5 funded positions dated · counts only3.9 years to maturity, weighted by fair value across the 4 dated positions.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No values on the capital structure — position counts only. With 3 lenders reporting, splitting the total along that dimension would give up a per-lender figure that sits behind the gate.
- No period-by-period totals across the 5 periods on record. A single filer is separable somewhere in that history — at a period only one of them reported, or in the difference between two — so the series would give up that filer's position.
- No filed seniority on 2 of 5 funded positions.
- No maturity on 1 of 5 funded positions. Undated is left undated, not assumed.
Sign up for free
Who holds it, and where they mark it.
3 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
3 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Blackstone Private Credit Fund (BCRED) | 0001803498 | 10-Q | 2026-06-30 | 2026-08-12 | 0001803498-26-000048 |
| Blackstone Secured Lending Fund (BXSL) | 0001736035 | 10-Q | 2026-06-30 | 2026-08-06 | 0001736035-26-000016 |
| Hercules Capital, Inc. (HTGC) | 0001280784 | 10-Q | 2026-06-30 | 2026-07-30 | 0001280784-26-000042 |
Related borrowers
Same lenders
Same sector